INS and diabetes mellitus: Following the reassuring results of the ARA MED 330 protocol for insulin-treated pilots [10], and given continuous advances in diabetes technology, updated evidence-based medical requirements are expected in Europe for insulin-treated aviation professionals previously deemed unfit for duties due to assumed hypoglycaemia-related incapacitation risk, classified as level 1 (3.0–3.8 mmol/L or 54–69 mg/dL) or level 2 (<3.0 mmol/L or <54 mg/dL) [11].